RETRACTED: Aberrant methylation of Reprimo in lung cancer
- 31 March 2005
- journal article
- retracted article
- Published by Elsevier in Lung Cancer
- Vol. 47 (3) , 309-314
- https://doi.org/10.1016/j.lungcan.2004.08.006
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Aberrant DNA Methylation in Lung Cancer: Biological and Clinical ImplicationsThe Oncologist, 2002
- The fundamental role of epigenetic events in cancerNature Reviews Genetics, 2002
- Checking out the G2/M transitionBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2001
- Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 PhaseJournal of Biological Chemistry, 2000
- The Hallmarks of CancerCell, 2000
- DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesisOncogene, 1999
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences, 1996
- Deletion mapping of chromosome 2 in human lung carcinomaGenes, Chromosomes and Cancer, 1996
- NCI-navy medical oncology branch cell line data baseJournal of Cellular Biochemistry, 1996
- [15] Isolation of genomic DNAPublished by Elsevier ,1987